Dear AuntMinnie Member,
It's all in how you slice it. At least that's the message from a research group out of California, which found that defining the region of interest of a tumor can play a major role in FDG-PET's ability to monitor a patient's response to therapy.
The researchers experimented with various methods of using PET/CT to track therapy response, and presented their research at this week's joint meeting of the Academy of Molecular Imaging and Society of Molecular Imaging. Staff writer Wayne Forrest has been on hand to report for our Molecular Imaging Digital Community.
Ultimately, the group found that three widely used methods of measuring standardized uptake values (SUVs) can vary in some respects, while proving to be remarkably similar in others. Find out more by clicking here.
In a second article from the meeting, another group (also from California) demonstrated its progress in developing a method for ultrasound-based molecular imaging using contrast agents. The group hopes its technique will provide a rapid and sensitive way to image targeted contrast media. Learn all about it by clicking here.
Get these stories and more, as well as upcoming coverage from the AMI/SMI meeting, in our Molecular Imaging Digital Community, at molecular.auntminnie.com.
